28 September 2023

Last updated: Wednesday 27 September 2023

Cancer (Oncology)

ASCO 2023 Strong data for lung and breast cancer drugs

New opportunities for small molecules in cancer

Development timelines for new oncology drugs

FDA guides on accelerated approvals in oncology

Oncology pipeline marked by multiple therapy types

Immunocore and Gadeta probe gamma delta T cell receptors

Novel oncology drugs approved in a year of change

Progressive increase in oncology drug approvals

Checkpoint inhibitors are focus at ESMO

Microbiome-based therapies as anti-cancer agents